Ascelia Pharma AB (publ) (STO:ACE)
Sweden · Delayed Price · Currency is SEK 0.5800
-0.0950 (-14.07%)
Oct 14, 2026, 5:29 PM CET
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 77.45 million as of October 14, 2026. It is the 42,229th most valuable company in the world and the 615th biggest in Sweden. Its market cap has decreased by 79.98% in one year.
Market Cap
77.45M
Enterprise Value
39.89M
Revenue
n/a
Global Rank
Country Rank
#615 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 77.45M, a decrease of -86.23%. That is a compound annual growth rate of -22.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 77.45M | -81.01% |
| Dec 30, 2025 | 407.88M | 45.35% |
| Dec 30, 2024 | 280.63M | 146.68% |
| Dec 29, 2023 | 113.76M | -77.38% |
| Dec 30, 2022 | 503.00M | -49.95% |
| Dec 30, 2021 | 1.00B | -36.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Initiator Pharma | 144.44M |
| Abera Bioscience AB | 140.62M |
| NextCell Pharma AB | 124.12M |
| OncoZenge AB | 104.47M |
| Active Biotech AB | 90.15M |
| Spago Nanomedical AB | 87.42M |
| Biovica International AB | 86.70M |
| Nanologica AB | 80.88M |